Correlation Between Cue Biopharma and Rallybio Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Rallybio Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Rallybio Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Rallybio Corp, you can compare the effects of market volatilities on Cue Biopharma and Rallybio Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Rallybio Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Rallybio Corp.

Diversification Opportunities for Cue Biopharma and Rallybio Corp

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cue and Rallybio is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Rallybio Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rallybio Corp and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Rallybio Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rallybio Corp has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Rallybio Corp go up and down completely randomly.

Pair Corralation between Cue Biopharma and Rallybio Corp

Considering the 90-day investment horizon Cue Biopharma is expected to generate 0.95 times more return on investment than Rallybio Corp. However, Cue Biopharma is 1.05 times less risky than Rallybio Corp. It trades about 0.0 of its potential returns per unit of risk. Rallybio Corp is currently generating about -0.01 per unit of risk. If you would invest  308.00  in Cue Biopharma on September 2, 2024 and sell it today you would lose (186.00) from holding Cue Biopharma or give up 60.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Cue Biopharma  vs.  Rallybio Corp

 Performance 
       Timeline  
Cue Biopharma 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cue Biopharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Cue Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.
Rallybio Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Rallybio Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Rallybio Corp may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Cue Biopharma and Rallybio Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cue Biopharma and Rallybio Corp

The main advantage of trading using opposite Cue Biopharma and Rallybio Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Rallybio Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rallybio Corp will offset losses from the drop in Rallybio Corp's long position.
The idea behind Cue Biopharma and Rallybio Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets